Barriers to Drug Delivery in Solid Tumors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1994-07

AUTHORS

R K Jain

ABSTRACT

N/A

PAGES

58-65

Journal

TITLE

Scientific American

ISSUE

1

VOLUME

271

Related Patents

  • Dual Acting Prodrugs
  • Treatment Of Hematologic Malignancies Associated With Circulating Tumor Cells Using Chimeric Anti-Cd20 Antibody
  • Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
  • Inhibition Of Cxcr4 Signaling In Cancer Immunotherapy
  • Method Of Treating Cancer With An Hla-A*3303-Restricted Wt1 Peptide And Pharmaceutical Composition Comprising The Same
  • Binding Domain-Immunoglobulin Fusion Proteins
  • Means For The Diagnosis And Therapy Of Ctcl
  • Peptides For Targeting Apoptotic Cells And Uses Thereof
  • Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acids And Polypeptides
  • Treatment Of Diffuse Large-Cell Lymphoma With Anti-Cd20 Antibody
  • Psf1-Derived Peptide
  • Pen-Type Electrosurgical Instrument
  • Methods Of Treatment Using Ctla-4 Antibodies
  • Therapeutic Method Of Treatment For Inhibiting Tumor Development Using Tamm-Horsfall Glycoprotein (Thp) As Immunostimulating Drug And Compositions
  • Anti-Rspo2 Antibodies And Uses Thereof
  • Versatile Hydrophilic Dyes
  • Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
  • Therapies Using Non-Natural Amino Acids And Polypeptides
  • Tumor-Targeted Optical Contrast Agents
  • Screening Assays For Agents That Alter Inhibitor Of Apoptosis (Iap) Protein Regulation Of Caspase Activity
  • Use Of Cyclic Depsipeptides To Inhibit Kallikrein 7
  • Androgen Regulated Prostate Specific Nucleic Acids
  • Synthetic Peptides And Their Use
  • Monoclonal Antibodies To Progastrin
  • Receptor-Avid Exogenous Optical Contrast And Therapeutic Agents
  • Nucleotide And Protein Sequence Of Mammastatin And Methods Of Use
  • Method Of Treating Cancer, Neoplastic Disorders, And Symptoms Thereof With Compounds
  • Gastrin Hormone Immunoassays
  • Methods And Compositions For Inhibition Of Bcl6 Repression
  • Methods And Compositions For Ameliorating The Undesirable Effects Of Chemotherapy
  • Glp-1 Agonist For Use In The Treatment Of Stenosis Or/And Obstruction In The Pancreatic Duct System
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Methods And Compositions For The Treatment Of Cancer
  • Dynamic Flow Imaging Phantom And Model Therefor
  • Anti-Epcam Antibodies And Methods Of Use
  • Treatment Of Chronic Lymphocytic Leukemia Using Anti-Cd20 Antibodies
  • Therapeutic Agent For Cancer Having Reduced Sensitivity To Molecular Target Drug And Pharmaceutical Composition For Enhancing Sensitivity To Molecular Target Drug
  • Streptavidin Expressed Gene Fusions And Methods Of Use Thereof
  • Treating Prostate Cancer With Anti-Erbb2 Antibodies
  • Hydrophilic Cyanine Dyes
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Monoclonal Antibodies Directed To The Her2 Receptor
  • Nucleotide And Protein Sequences Of Lats Genes And Methods Based Thereon
  • Method For Making Humanized Antibodies
  • Anti-Inflammatory Peptides And Composition Comprising The Same
  • Compositions And Methods For Modulating The Immune System
  • Treatment Of Dermal Fibrosis
  • Anti-Kidney Associated Antigen 1 (Kaag1) Antibodies
  • Further Use Of Protein Kinase N Beta
  • Use Of Ave0010 For The Treatment Of Diabetes Mellitus Type 2
  • Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
  • Pharmaceutical Composition For Treatment Of Radiation- Or Drug-Resistant Cancer Comprising Hrp-3 Inhibitor
  • Peptides For Targeting Apoptotic Cells And Uses Thereof
  • Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer
  • Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer
  • Enzymatic Debridement Therapy For Abnormal Cell Proliferation
  • Anti-Neoplastic Compositions Comprising Extracts Of Black Cohosh
  • Methods And Compositions For Selective Modulation Of Vascularization
  • Immunity Inducing Agent
  • Therapy For Mll-Rearranged Leukemia
  • Microphthalmia-Associated Transcription Factor-Derived Peptide And Composition Containing Same
  • Anti-Clusterin Antibodies And Antigen Binding Fragments And Their Use To Reduce Tumor Volume
  • Binding Domain-Immunoglobulin Fusion Proteins
  • Solution Phase Processes For The Manufacture Of Macrocyclic Depsipeptides And New Intermediates
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Fcε-Pe Chimeric Protein For Targeted Treatment Of Allergy Responses A Method For Its Production And Pharmaceutical Compositions Containing The Same
  • Use Of A Peptide In The Treatment Or Prevention Of Metastasis
  • Macrocyclic Lactone Compounds And Methods For Their Use
  • Identification And Engineering Of Antibodies With Variant Fc Regions And Methods Of Using Same
  • Fk 228 Derivates As Hdac Inhibitors
  • Muc18 Targeting Peptides
  • Formulations For Therapeutic Administration Of Thyroid Stimulating Hormone (Tsh)
  • Fcepsilon-Pe Chimeric Protein For Targeted Treatment Of Allergy Responses A Method For Its Production And Pharmaceutical Compositions Containing The Same
  • Method Of Ablating Tissue
  • Composition And Method For Diagnosis And Immunotherapy Of Prostate Cancer
  • Tetrapeptide Having Effect Of Inhibiting Vegf-Induced Angiogenesis And Use Thereof
  • Immunogenic Epitopes For Immunotherapy
  • Insulin Glargine/Lixisenatide Fixed Ratio Formulation
  • Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
  • Pharmaceutical Composition Comprising A Glp-1-Agonist And Methionine
  • Peptide For The Prophylactic Or Therapeutic Treatment Of Skin Tumors In Initial Stages
  • Dual Acting Prodrugs
  • Methods For Inhibiting Hematopoiesis With A Hedgehog Antagonist
  • Uses Of Apoptotic Cell-Targeting Peptides, Label Substances And Liposomes Containing A Therapeutic Agent For Preventing, Treating Or Therapeutically Diagnosing Apoptosis-Related Diseases
  • Identification And Treatment Of Cancer Subsets
  • Peptide Derivatives Of Exendin-4
  • Therapy For Mll-Rearranged Leukemia
  • Peptides Derived From Nkp44
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Immunity Induction Agent
  • Inhibition Of Tumor Growth With Aggregates Of Small Molecules
  • Psf1-Derived Peptide
  • Antibodies Reactive With B7-H3 And Uses Thereof
  • Stable Pentadecapeptide Salts, A Process For Preparation Thereof, A Use Thereof In The Manufacture Of Pharmaceutical Preparations And A Use Thereof In Therapy
  • Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acids And Polypeptides
  • Polypeptide, Nucleotide Sequence Thereof, And Method For Using The Same For Preventing Dna Synthesis And Inhibiting Cell Proliferation
  • Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
  • Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acids And Polypeptides
  • Solution Phase Processes For The Manufacture Of Macrocyclic Depsipeptides And New Intermediates
  • Immunity Inducing Agent
  • Anti-Epcam Antibodies And Methods Of Use
  • Therapies Using Non-Natural Amino Acids And Polypeptides
  • Versatile Hydrophilic Dyes
  • Tumor-Targeted Optical Contrast Agents
  • Pen-Type Electrosurgical Instrument
  • Therapy For Mll-Rearranged Leukemia
  • Treatment Of Chronic Lymphocytic Leukemia Using Anti-Cd20 Antibodies
  • Monoclonal Antibodies Directed To The Her2 Receptor
  • Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer
  • Compositions And Methods For The Therapy And Diagnosis Of Breast Cancer
  • Streptavidin Expressed Gene Fusions And Methods Of Use Thereof
  • Treating Prostate Cancer With Anti-Erbb2 Antibodies
  • Hydrophilic Cyanine Dyes
  • Nucleotide And Protein Sequences Of Lats Genes And Methods Based Thereon
  • Peptides For Targeting Apoptotic Cells And Uses Thereof
  • Humanized Fcγriib-Specific Antibodies And Methods Of Use Thereof
  • Enzymatic Debridement Therapy For Abnormal Cell Proliferation
  • Method For Making Humanized Antibodies
  • Anti-Neoplastic Compositions Comprising Extracts Of Black Cohosh
  • Methods And Compositions For Selective Modulation Of Vascularization
  • Means For The Diagnosis And Therapy Of Ctcl
  • Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
  • Binding Domain-Immunoglobulin Fusion Proteins
  • Inhibition Of Cxcr4 Signaling In Cancer Immunotherapy
  • Method Of Treating Cancer With An Hla-A*3303-Restricted Wt1 Peptide And Pharmaceutical Composition Comprising The Same
  • Anti-Rspo2 Antibodies And Uses Thereof
  • Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
  • Therapeutic Method Of Treatment For Inhibiting Tumor Development Using Tamm-Horsfall Glycoprotein (Thp) As Immunostimulating Drug And Compositions
  • Therapeutic Agent For Cancer Having Reduced Sensitivity To Molecular Target Drug And Pharmaceutical Composition For Enhancing Sensitivity To Molecular Target Drug
  • Binding Domain-Immunoglobulin Fusion Proteins
  • Microphthalmia-Associated Transcription Factor-Derived Peptide And Composition Containing Same
  • Anti-Clusterin Antibodies And Antigen Binding Fragments And Their Use To Reduce Tumor Volume
  • Fcγriib Specific Antibodies And Methods Of Use Thereof
  • Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
  • Immunogenic Epitopes For Immunotherapy
  • Insulin Glargine/Lixisenatide Fixed Ratio Formulation
  • Peptides Derived From Nkp44
  • Bispecific Molecules That Are Immunoreactive With Immune Effector Cells Of A Companion Animal That Express An Activating Receptor And Cells That Express B7-H3 And Uses Thereof
  • Identification And Treatment Of Cancer Subsets
  • Methods For Inhibiting Hematopoiesis With A Hedgehog Antagonist
  • Peptide For The Prophylactic Or Therapeutic Treatment Of Skin Tumors In Initial Stages
  • Dual Acting Prodrugs
  • Muc-1 Cytoplasmic Domain Peptides As Inhibitors Of Cancer
  • Human Tissue Factor Antibody And Uses Thereof
  • Her2/Neu-Specific Antibodies And Methods Of Using Same
  • Identification And Treatment Of Cancer Subsets
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/scientificamerican0794-58

    DOI

    http://dx.doi.org/10.1038/scientificamerican0794-58

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1024159067

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/8066425


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "author": [
          {
            "affiliation": {
              "name": [
                "Department of Radiation Oncology, Harvard Medical School."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jain", 
            "givenName": "R K", 
            "type": "Person"
          }
        ], 
        "datePublished": "1994-07", 
        "datePublishedReg": "1994-07-01", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/scientificamerican0794-58", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018656", 
            "issn": [
              "0036-8733", 
              "1946-7087"
            ], 
            "name": "Scientific American", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "271"
          }
        ], 
        "name": "Barriers to Drug Delivery in Solid Tumors", 
        "pagination": "58-65", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "7318c0aef0b4b4822e162f41d0932a7e4f5387bbd2c56e5ed78a984dfc5f866c"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "8066425"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0404400"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/scientificamerican0794-58"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1024159067"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/scientificamerican0794-58", 
          "https://app.dimensions.ai/details/publication/pub.1024159067"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T00:55", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000424.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://full/.html"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/scientificamerican0794-58'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/scientificamerican0794-58'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/scientificamerican0794-58'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/scientificamerican0794-58'


     

    This table displays all metadata directly associated to this object as RDF triples.

    58 TRIPLES      18 PREDICATES      26 URIs      20 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/scientificamerican0794-58 schema:author Nee2944fa02c84ed5b7553b813f64f411
    2 schema:datePublished 1994-07
    3 schema:datePublishedReg 1994-07-01
    4 schema:genre research_article
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:isPartOf N8e562fdcd99542edbb3571b3e6dde332
    8 Nb1db8a5716244c12a9d7558d7138d803
    9 sg:journal.1018656
    10 schema:name Barriers to Drug Delivery in Solid Tumors
    11 schema:pagination 58-65
    12 schema:productId N10f4f633dea74685828bbe4d9f13ca87
    13 N66f87902044343c09fd781d51f58c46f
    14 N74a1f89410c642a9a327b9e044bf6e5b
    15 N8e87063959aa4ccdb1fb4e080f680d47
    16 N90ced64843d248b3ae927d1f89fdbe27
    17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024159067
    18 https://doi.org/10.1038/scientificamerican0794-58
    19 schema:sdDatePublished 2019-04-11T00:55
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher N767c470388f54b86a32b36c254ff8dc8
    22 schema:url http://full/.html
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset articles
    25 rdf:type schema:ScholarlyArticle
    26 N10f4f633dea74685828bbe4d9f13ca87 schema:name doi
    27 schema:value 10.1038/scientificamerican0794-58
    28 rdf:type schema:PropertyValue
    29 N66f87902044343c09fd781d51f58c46f schema:name readcube_id
    30 schema:value 7318c0aef0b4b4822e162f41d0932a7e4f5387bbd2c56e5ed78a984dfc5f866c
    31 rdf:type schema:PropertyValue
    32 N74a1f89410c642a9a327b9e044bf6e5b schema:name dimensions_id
    33 schema:value pub.1024159067
    34 rdf:type schema:PropertyValue
    35 N767c470388f54b86a32b36c254ff8dc8 schema:name Springer Nature - SN SciGraph project
    36 rdf:type schema:Organization
    37 N793c137d865a452d9a7e5e4b39d5dfff schema:affiliation Nb1aee2a6160c43d3bb752e89521b314e
    38 schema:familyName Jain
    39 schema:givenName R K
    40 rdf:type schema:Person
    41 N8e562fdcd99542edbb3571b3e6dde332 schema:issueNumber 1
    42 rdf:type schema:PublicationIssue
    43 N8e87063959aa4ccdb1fb4e080f680d47 schema:name pubmed_id
    44 schema:value 8066425
    45 rdf:type schema:PropertyValue
    46 N90ced64843d248b3ae927d1f89fdbe27 schema:name nlm_unique_id
    47 schema:value 0404400
    48 rdf:type schema:PropertyValue
    49 Nb1aee2a6160c43d3bb752e89521b314e schema:name Department of Radiation Oncology, Harvard Medical School.
    50 rdf:type schema:Organization
    51 Nb1db8a5716244c12a9d7558d7138d803 schema:volumeNumber 271
    52 rdf:type schema:PublicationVolume
    53 Nee2944fa02c84ed5b7553b813f64f411 rdf:first N793c137d865a452d9a7e5e4b39d5dfff
    54 rdf:rest rdf:nil
    55 sg:journal.1018656 schema:issn 0036-8733
    56 1946-7087
    57 schema:name Scientific American
    58 rdf:type schema:Periodical
     




    Preview window. Press ESC to close (or click here)


    ...